jc
jc

News Center

Check category
/
/
/
West China Hospital, Department of Cardiology, the ninth TAVI training course successfully concluded

West China Hospital, Department of Cardiology, the ninth TAVI training course successfully concluded

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-10-10 13:45
  • Views:

(Summary description)

West China Hospital, Department of Cardiology, the ninth TAVI training course successfully concluded

(Summary description)

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-10-10 13:45
  • Views:
Information

S

 

S

 

  September 29, led by Professor Guo Yingjiang Huaxi Hospital heart surgery team, including Professor Chen Yucheng Cardiology, Cardiac Surgery Zhu Da, anesthesia Liang Peng physician, successfully held the first 9 TAVI surgery course. China Medical University First Affiliated Hospital, Zhengzhou University First Affiliated Hospital of the heart team involved in the training and exchange.

 

X

 

X

 

  Patient history data
  This training was first conducted by J-Valve? by TA6 surgery. This is the 91 cases of J-Valve? implanted in West China Hospital. The patient is a 77-year-old male, 2 months ago after the activities of the heart, the recent symptoms of no relief. Recently in the clinic to "aortic stenosis with incomplete" treatment. Heart ultrasound diagnosis: aortic valve - severe stenosis, mild reflux. After discussion with the Heart Team, it was decided to use J-Valve? for TA-TAVI surgery. CTA results show that the aortic valve has been evaluated and discussed. Heart Team decided to choose a 25mm J-Valve? intervention valve.


  Surgery process
  Surgery in the West China Hospital heart hybrid surgery room to complete the internal jugular vein placement of temporary pacing wire. DR to determine the location of the apex puncture, line 3cm minimally invasive incision. Suspension pericardium and apical purse suture. The femoral artery was implanted into the 5F sheath and the liver was placed in the pigtail catheter to the aortic root (ACT> 250s), and the optimal projection angle was obtained.
  ▌ ultrasound and DR guide apical puncture, into the 1.8m J-Tip guide wire to the ascending aorta, into the vascular sheath, using JR4 catheter guide wire across the aortic arch to the descending aorta, replace the 2.6m plus hard guide wire.
  1. Release the positioning key and pull back to the three aortic valve sinus, angiography confirmed positioning key position is correct.
  2. Retract the valve, the stent valve under the guidance of the positioning key into the aortic valve area.
  3. Rotate release button, valve release (due to self-expanding valve, the whole process without RVP and any hemodynamic fluctuations).
  4. Recycling device, release valve, angiography and TEE real valve position is good, no valve weeks leakage. Stitch the apical incision, the apex without bleeding, one by one to close the incision.


  Surgical summary
  ▌ the whole operation of a total of 30 minutes, the patient recovered well after surgery
  ▌ After the operation, the core members of Huaxi Cardiac Surgery Team, Professor Chen Yucheng, Zhu Da, Liang Peng, conducted the TAVI technical complications and prevention, the main points of image analysis and TAVI surgery anesthesia and other key lectures. Prof. Guo Yingjiang has conducted detailed and vivid analysis and sharing of J-Valve? project initiation and surgical review.

 

X

 

X

 

  Professor Gu Tianxiang from the First Affiliated Hospital of China Medical University and the team of the first affiliated hospital of Zhengzhou University, Professor Qiao Chenhui, operated the simulated implant device and discussed the key steps of the operation.

 

X

 

  ▌ Sichuan University Huaxi Hospital, the heart of the team under the leadership of Professor Guo Yingjiang, in the West China Hospital completed J-Valve? interventional valve surgery in 91 cases, not only by the pericardial involvement of the heart of the largest cardiac center, West China Hospital has also for the national centers A total of nine training sessions were conducted to train 28 heart centers and published on JACC, JACC intervention and International Journal of Cardiology. There were 10 articles on J-Valve? involved in high-impact factors related to valve surgery (non-review) Factor of more than 40 points, completed TAVI treatment of simple reflux cases refer to the relevant published literature is currently the world's first.
  ▌J-Valve? artificial interventional biological heart valve is a new generation of interventional valve, in April 2017 access to the State Food and Drug Administration approved clinical use, the indications include aortic stenosis, aortic valve insufficiency and aortic stenosis Merger is not complete, is the only one in the world to obtain official approval to treat aortic valve insufficiency of the interventional valve, but also aortic valve disease one-stop solution.

 

X

Contact us

这是描述信息

+86-512-63179788(WJ) | +86-512-63036288(SZ)

这是描述信息

Building4-1,Hi-Tech Park, Wujiang, Jiangsu Province, China

C21 Building, 218 Xinghu Street, Suzhou Industrial Park, China

这是描述信息

215200

FOLLOW US

这是描述信息

Mobile Website

这是描述信息

WeChat

Copyright ©  Suzhou Jiecheng Medical Technology Co., Ltd. 

这是描述信息